Trade Mark Journal No.2026/020 15 May 2026
WO0000001915559 (5)
Office of origin: United States of America
Date of International Registration:2 April 2026
Date of designation in the UK:
2 April 2026

International priority date claimed: 8 October 2025
(United States of America)
(99432489)
- Class 5
- Pharmaceutical preparations for the treatment of eye diseases and conditions.
Tenpoint Therapeutics Holding Limited
Representative: Joshua G. Gigger STOEL RIVES, 201 South Main Street,, Suite 205, Salt Lake City UT 84111, UNITED STATES OF AMERICA